Mid-Day Market Update: StoneCo Drops After Q3 Earnings; EyePoint Pharmaceuticals Shares Surge

Midway through trading Wednesday, the Dow traded down 0.51% to 35,958.22 while the NASDAQ rose 0.03% to 15,977.88. The S&P also fell, dropping 0.13% to 4,694.96.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 48,161,370 cases with around 786,260 deaths. India confirmed a total of at least 34,466,590 cases and 464,150 deaths, while Brazil reported over 21,965,680 COVID-19 cases with 611,520 deaths. In total, there were at least 255,259,860 cases of COVID-19 worldwide with more than 5,133,290 deaths, according to data compiled by Johns Hopkins University.


Leading and Lagging Sectors


Consumer discretionary shares gained by 0.7% on Wednesday. Meanwhile, top gainers in the sector included Dogness (International) Corporation DOGZ, up 19% and Zhangmen Education Inc. ZME up 20%.


In trading on Wednesday, financials shares fell 1.2%.


Top Headline


Lowe's Companies, Inc. LOW reported better-than-expected results for its third quarter on Wednesday.

Lowe's Companies posted quarterly earnings of $2.73 per share, beating analysts’ estimates of $2.35 per share. The company’s quarterly sales came in at $22.90 billion, versus expectations of $21.99 billion.


Equities Trading UP


Sono Group N.V. Common SEV shares shot up 83% to $27.40 after the company priced its IPO at $15 per share.


Shares of Tattooed Chef, Inc. TTCF got a boost, shooting 16% to $18.44 as the company announced Q3 results.


EyePoint Pharmaceuticals, Inc. EYPT shares were also up, gaining 27% to $17.79. EyePoint Pharmaceuticals priced an underwritten public offering of 4.03 million at $13.75 per share and pre-funded warrants to purchase up to an aggregate of 3.27 million shares at $13.74 per pre-funded warrant.

Check out these big movers of the day


Equities Trading DOWN

StoneCo Ltd. STNE shares tumbled 31% to $21.93 after the company reported worse-than-expected Q3 earnings.


Shares of Cyclo Therapeutics, Inc. CYTH were down 23% to $5.68. Cyclo Therapeutics priced its previously announced underwritten public offering of 1.95 million shares at $6.00 per share, with gross proceeds of $11.7 million.


Cassava Sciences, Inc. SAVA was down, falling 24% to $46.65 following reports suggesting the SEC is probing the company


Commodities

In commodity news, oil traded down 1.8% to $79.35, while gold traded up 0.7% to $1,867.00.


Silver traded up 0.9% Wednesday to $25.165 while copper fell 1.7% to $4.2780.


Euro zone

European shares were mostly higher today. The eurozone’s STOXX 600 gained 0.19%, the Spanish Ibex Index fell 0.2% and the German DAX 30 gained 0.12%. Meanwhile, the London’s FTSE 100 fell 0.37%, French CAC 40 rose 0.19% and Italy’s FTSE MIB rose 0.17%.

Annual inflation rate in the UK surged to 4.2% in October, recording the highest level since December 2011. The headline rate of output prices in the UK increased to 8.0% year-over-year in October.


Economics


Housing starts dropped 0.7% to an annualized rate of 1.52 million in October, while building permits climbed 4% from a month ago to an annual rate of 1.650 million.


US crude oil inventories dropped 2.101 million barrels in the week ending November 12, following a 1.001 million rise in the prior period, the Energy Information Administration said.


San Francisco Federal Reserve Bank President Mary Daly is set to speak at 12:40 p.m. ET.


Federal Reserve Governor Christopher Waller will speak at 12:40 p.m. ET.


Federal Reserve Bank of Cleveland President Loretta Mester is set to speak at 12:40 p.m. ET.


The Treasury is set to auction 20-year bonds at 1:00 p.m. ET.


Federal Reserve Bank of Chicago President Charles Evans will speak at 4:05 p.m. ET.


Federal Reserve Bank of Atlanta President Raphael Bostic is set to speak at 4:10 p.m. ET.

Check out the full economic calendar here

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!